πŸ‡ΊπŸ‡Έ FDA
Patent

US 11957675

Methods and uses for treating anhedonia

granted A61KA61K31/472A61P

Quick answer

US patent 11957675 (Methods and uses for treating anhedonia) held by Xenon Pharmaceuticals Inc. expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
36
CPC classes
A61K, A61K31/472, A61P, A61P25/24